Key Metrics 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Medinova Diagnostic Services Ltd. - (Amalgamated) (526301)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526301 NSE: Hospital & Healthcare Services | Small Cap | Medinova Amalgamatio Share Price
₹43.45 0.00 (0.00%)
As on 24-Nov'25 16:59
Medinova Diagnostic Services Ltd. - (Amalgamated) (526301)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526301 NSE: Hospital & Healthcare Services | Small Cap | Medinova Amalgamatio Share Price
₹43.45 0.00 (0.00%)
As on 24-Nov'25 16:59
Key Metrics
Valuation Multiples
Market Cap
₹43 Cr.
Current Price
₹43.5
52-Week Low / High
₹37 / 46
TTM EPS
₹1.1
TTM Sales
₹7.7 Cr.
Book Value per Share
₹-0.6
P/E Ratio
40.57
Higher than its 5-year historical median
Industry PE
93.9
Price to Book (P/B)
-75.23
Lower than its 5-year historical median
Price to Sales (P/S)
5.65
Higher than its 5-year historical median
EV/EBITDA
21.80
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
51.29%
Return on Assets (ROA)
15.15%
Operating Profit Margin
23.6%
Net Profit Margin
11.78%
Gross Profit Margin
17.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-2.96%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
17.45%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
18.67%
Asset Quality
Promoter Holding
62.14%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-11 Cr.
Equity
₹10 Cr.
Face Value
₹10
All Time Low / High
₹1.00 / 64.50
10 Year X-Ray : Login to view analysis.
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medinova Diagnostic Services Ltd. - (Amalgamated) has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 56.9% | 55.5% | 51.3% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | NA | 3.1 | 3.0 | 2.7 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 7 | 6 | 6.7 | 6.7 | 5.5 | 11.3 | 11.5 | 7.8 | 7.8 | 7.6 | 8 |
| Sales YoY Gr. | - | -14.1% | 11.2% | 0.9% | -18.6% | 106.2% | 1.7% | -32.6% | 0.3% | -3% | - |
| Adj EPS ⓘ | -1.7 | -1.7 | -1 | -0.4 | -0.3 | 2.2 | 2.1 | 0.6 | 0.8 | 0.9 | 1.1 |
| YoY Gr. | - | NA | NA | NA | NA | NA | -4.2% | -69.7% | 19.1% | 21.3% | - |
| BVPS (₹) ⓘ | -8.9 | -8 | -8.2 | -7.4 | -7.7 | -5.6 | -3.5 | -2.8 | -2.1 | -1.2 | -0.6 |
| Adj Net Profit ⓘ | -1.6 | -1.7 | -1 | -0.4 | -0.3 | 2.2 | 2.1 | 0.6 | 0.8 | 0.9 | 1 |
| Cash Flow from Ops. ⓘ | 1.8 | -0.7 | 0.4 | 0.5 | 0.4 | 1.5 | 1.1 | 1.2 | 1.5 | 1.4 | - |
| Debt/CF from Ops. ⓘ | 2.7 | -7.3 | 13.3 | 8.6 | 10.3 | 2.2 | 5.1 | 4.9 | 3.3 | 3.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 0.8% | 6.6% | -13.1% | -3% | ||||
| Adj EPS ⓘ | NA | NA | -24.1% | 21.3% | ||||
| BVPSⓘ | NA | NA | NA | NA | ||||
| Share Price | 3.2% | 1.3% | 21.9% | 6% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 20.8 | 21 | 12.5 | 4.7 | 3.9 | -32.7 | -46 | -20 | -30.7 | -55.9 | -120.2 |
| Op. Profit Mgn % ⓘ | -6.8 | -10.8 | -2.9 | 4.5 | 5.5 | 23.2 | 26.5 | 19.1 | 19.2 | 23.6 | 26.1 |
| Net Profit Mgn % ⓘ | -22.6 | -28.6 | -15.1 | -5.4 | -5.4 | 19.1 | 18 | 8.1 | 9.7 | 12.1 | 13.9 |
| Debt to Equity ⓘ | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -1.7 | -2 | -2.4 | -4.2 | - |
| Working Cap Days ⓘ | 146 | 130 | 75 | 60 | 70 | 40 | 38 | 53 | 50 | 48 | 37 |
| Cash Conv. Cycle ⓘ | -193 | -258 | -290 | -321 | -433 | -212 | -177 | -208 | -184 | -195 | -28 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 6.01 | 6.68 | 6.74 | 5.49 | 11.32 | 11.51 | 7.76 | 7.78 | 7.55 |
| Operating Expenses ⓘ + | 7.50 | 6.66 | 7.02 | 6.44 | 5.19 | 8.69 | 8.47 | 6.28 | 6.29 | 5.80 |
| Operating Profit ⓘ | -0.50 | -0.65 | -0.34 | 0.30 | 0.30 | 2.63 | 3.05 | 1.48 | 1.49 | 1.75 |
| Operating Profit Margin (%) | -7.1% | -10.8% | -5.1% | 4.5% | 5.5% | 23.2% | 26.5% | 19.1% | 19.1% | 23.2% |
| Other Income ⓘ + | 0.26 | 0.21 | 0.07 | 0.17 | 0.26 | 0.29 | 0.22 | 0.23 | 0.26 | 0.12 |
| Interest ⓘ | 0.41 | 0.62 | 0.48 | 0.43 | 0.42 | 0.31 | 0.45 | 0.61 | 0.61 | 0.53 |
| Depreciation ⓘ | 0.81 | 1.25 | 0.86 | 0.55 | 0.41 | 0.32 | 0.26 | 0.24 | 0.12 | 0.14 |
| Profit Before Tax ⓘ | -1.46 | -0.68 | 0.02 | 1.10 | -0.27 | 2.29 | 2.55 | 0.87 | 1.02 | 1.19 |
| Tax ⓘ | 0.13 | -0.10 | -0.01 | 0.34 | 0.03 | 0.13 | 0.48 | 0.24 | 0.26 | 0.30 |
| Profit After Tax | -1.60 | -0.58 | 0.03 | 0.77 | -0.30 | 2.17 | 2.07 | 0.63 | 0.75 | 0.89 |
| PAT Margin (%) | -22.8% | -9.6% | 0.4% | 11.4% | -5.4% | 19.1% | 18.0% | 8.1% | 9.7% | 11.8% |
| Adjusted EPS (₹) | -1.7 | -0.6 | 0.0 | 0.8 | -0.3 | 2.2 | 2.1 | 0.6 | 0.8 | 0.9 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Valuation of Medinova Amalgamatio - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | -8.38 | -7.98 | -8.13 | -7.38 | -7.68 | -5.56 | -3.47 | -2.83 | -2.07 | -1.20 | |
| Debt + | 4.31 | 4.56 | 4.26 | 3.91 | 4.03 | 3.27 | 5.75 | 5.75 | 5 | 5 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 4.10 | 4.06 | 4.25 | 4.69 | 4.85 | 4.36 | 3.24 | 2.41 | 2.32 | 2.31 | |
| Others Liabilities ⓘ | 8.12 | 5.32 | 4.08 | 2.54 | 2.41 | 2.18 | 0.56 | 0.44 | 0.26 | 0.11 | |
| Total Liabilities ⓘ | 8.15 | 5.96 | 4.45 | 3.76 | 3.61 | 4.26 | 6.08 | 5.77 | 5.51 | 6.23 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 4.33 | 3.22 | 1.84 | 1.44 | 1.03 | 0.90 | 0.80 | 0.95 | 1.02 | 1.32 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 0.94 | 1.15 | 1.29 | 1.27 | 1.27 | 1.27 | 2.97 | 2.97 | 2.97 | 2.97 | |
| Inventories | 0.14 | 0.08 | 0.07 | 0.07 | 0.06 | 0.13 | 0.17 | 0.11 | 0.10 | 0.12 | |
| Trade Receivables | 0.47 | 0.30 | 0.17 | 0.40 | 0.31 | 0.77 | 0.50 | 0.67 | 0.37 | 0.48 | |
| Cash Equivalents | 0.11 | 0.07 | 0.10 | 0.05 | 0.21 | 0.71 | 1.31 | 0.61 | 0.61 | 0.88 | |
| Others Assets ⓘ | 2.16 | 1.13 | 0.99 | 0.53 | 0.73 | 0.48 | 0.34 | 0.45 | 0.44 | 0.46 | |
| Total Assets ⓘ | 8.15 | 5.96 | 4.45 | 3.76 | 3.61 | 4.26 | 6.08 | 5.77 | 5.51 | 6.23 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 1.76 | -0.69 | 0.36 | 0.52 | 0.42 | 1.51 | 1.13 | 1.18 | 1.51 | 1.37 |
| Cash Flow From Investing Activity ⓘ + | -4.17 | -0.31 | 0.23 | -0.13 | -0.14 | -0.11 | -1.84 | -0.34 | -0.18 | -0.47 |
| Cash Flow From Financing Activity ⓘ + | 2.48 | 0.97 | -0.56 | -0.43 | -0.27 | -1.15 | 0.94 | -0.78 | -1.32 | -0.63 |
| Net Cash Flow ⓘ | 0.06 | -0.03 | 0.02 | -0.04 | 0.01 | 0.25 | 0.24 | 0.06 | -0 | 0.27 |
Financial Ratio
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ROCE (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Asset Turnover Ratio | 1.08 | 0.85 | 1.28 | 1.64 | 1.49 | 2.88 | 2.23 | 1.31 | 1.38 | 1.29 |
| PAT to CFO Conversion(x) | N/A | N/A | 12 | 0.68 | N/A | 0.7 | 0.55 | 1.87 | 2.01 | 1.54 |
| Working Capital Days | ||||||||||
| Receivable Days | 31 | 23.30 | 13 | 15.40 | 23.30 | 17.40 | 20.20 | 27.60 | 24.50 | 20.50 |
| Inventory Days | 8.50 | 7 | 4.20 | 3.70 | 4.40 | 3.10 | 4.70 | 6.50 | 5 | 5.30 |
| Payable Days | 1,389.70 | 1,515.10 | 1,235.80 | 1,453.90 | 2,034 | 1,146.10 | 569.50 | 891.10 | 1,008.50 | 1,687.20 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Medinova Diagnostic Services Ltd. - (Amalgamated) FAQs
The current trading price of Medinova Amalgamatio on 24-Nov-2025 16:59 is ₹43.45.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Nov-2025 the market cap of Medinova Amalgamatio stood at ₹43.37 Cr
The latest P/E ratio of Medinova Amalgamatio as of 23-Nov-2025 is 40.57.
The latest P/B ratio of Medinova Amalgamatio as of 23-Nov-2025 is -75.23.
The 52-week high of Medinova Amalgamatio is ₹46.00 and the 52-week low is ₹37.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medinova Amalgamatio is ₹7.68 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Medinova Diagnostic Services Ltd. - (Amalgamated) is a average quality company.
The key valuation ratios of Medinova Diagnostic Services Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Overvalued zone.
No data found
About Medinova Diagnostic Services Ltd. - (Amalgamated)
Medinova diagnostic services was established in the year 1985 as a pioneering concept in Diagnostics. For the first time in the country it offered all the diagnostic services from an ordinary blood test to a sophisticated CT Scan under one roof. With its qualitative services for more than two decades and with innovative marketing efforts, Medinova has created a brand name for itself and is the pioneer in Medical Diagnostics in the Country.
Medinova gives emphasis on providing quality services and is equipped with the latest state of the art diagnostic equipment procured from World renowned suppliers like GE, Marquette, Siemens, Hitachi etc. The quality of the tests done by Centres of Medinova meet international standards.Medinova has upgraded its equipment to make best use of latest technology.
Business area of the company
The Company is engaged in the business of providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
